Search Results - "Torre‐Cisneros, Julian"
-
1
-
2
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase‐producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia
Published in American journal of transplantation (01-06-2020)“…Treatment of carbapenemase‐producing Enterobacterales bloodstream infections in solid organ transplant recipients is challenging. The objective of this study…”
Get full text
Journal Article -
3
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023
Published in Transplant infectious disease (01-02-2024)“…The 2023 International CMV Symposium took place in Barcelona in May 2023. During the 2‐day meeting, delegates and faculty discussed the ongoing challenge of…”
Get full text
Journal Article -
4
Extended‐spectrum β‐lactamase‐producing and carbapenem‐resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches
Published in Transplant infectious disease (01-08-2022)“…Background Infections caused by multidrug‐resistant gram‐negative bacilli (MDR GNB), in particular extended‐spectrum β‐lactamase‐producing (ESBL‐E) and…”
Get full text
Journal Article -
5
Cytomegalovirus in transplantation - challenging the status quo
Published in Clinical transplantation (01-03-2007)“…: Background: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients causes both ‘‘direct’’ and ‘‘indirect’’ effects including allograft…”
Get full text
Journal Article -
6
Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: A multinational survey
Published in Transplant infectious disease (01-10-2019)“…Background There is no consensus on the optimal management of immunosuppression during bacterial infections among solid organ transplant recipients. Methods A…”
Get full text
Journal Article -
7
Impact of Current Transplantation Management on the Development of Cytomegalovirus Disease after Renal Transplantation
Published in Clinical infectious diseases (01-10-2008)“…Background. Current advances in transplantation practices may influence the development of cytomegalovirus (CMV) disease after renal transplantation. Methods…”
Get full text
Journal Article -
8
Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant
Published in Liver transplantation (01-06-2008)“…Surgical site infections are common bacterial infections in orthotopic liver transplantation. The purpose of this study was to determine the incidence, timing,…”
Get full text
Journal Article -
9
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
Published in Transplant infectious disease (01-12-2022)“…The CMV Symposium in September 2021 was an international conference dedicated to cytomegalovirus (CMV) infection after solid organ or hematopoietic stem cell…”
Get full text
Journal Article -
10
Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection
Published in Journal of clinical medicine (22-12-2020)“…Bezlotoxumab is marketed for the prevention of recurrent infection (rCDI). Its high cost could be determining its prescription to a different population than…”
Get full text
Journal Article -
11
Posttransplant Lymphoproliferative Disease in Primary Epstein-Barr Virus Infection after Liver Transplantation: The Role of Cytomegalovirus Disease
Published in The Journal of infectious diseases (01-12-1997)“…Epstein-Barr virus (EBV) plays a major role in the pathogenesis of posttransplant lymphoproliferative disease (PTLD). Patients who undergo primary EBV…”
Get full text
Journal Article -
12
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
Published in Journal of antimicrobial chemotherapy (01-03-2020)“…Abstract Objectives To investigate pharmacokinetics (PK) and safety (primary objectives) and efficacy (secondary objective) of the investigational…”
Get full text
Journal Article -
13
Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients
Published in Transplant infectious disease (01-12-2016)“…Appropriate post‐transplant immunosuppressive regimens that avoid acute rejection, while reducing risk of viral reactivation, have been sought, but remain a…”
Get full text
Journal Article -
14
CLINICAL EFFICACY OF CEFTAZIDIME/AVIBACTAM VERSUS OTHER ACTIVE AGENTS FOR THE TREATMENT OF BACTEREMIA DUE TO CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE IN HEMATOLOGIC PATIENTS
Published in International journal of infectious diseases (01-06-2017)“…Highlights • The majority of CPE corresponded to OXA-48 isolations. • CPE bacteremia is associated with high mortality in hematologic patients. • Mortality was…”
Get full text
Journal Article -
15
Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial
Published in Antimicrobial agents and chemotherapy (15-02-2022)“…The objective of this study was to investigate the efficacy and safety of early treatment with sarilumab, added to standard of care (SOC), in hospitalized…”
Get full text
Journal Article -
16
Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae
Published in Journal of antimicrobial chemotherapy (01-11-2016)“…Invasive infections caused by KPC-producing Klebsiella pneumoniae (KPCKP) are associated with very high mortality. Because infection is usually preceded by…”
Get full text
Journal Article -
17
Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing
Published in PloS one (18-07-2019)“…The aim of this study was to identify CMV drug resistance mutations (DRM) in solid organ transplant (SOT) recipients with suspected resistance comparing…”
Get full text
Journal Article -
18
Tuberculosis after Solid-Organ Transplant: Incidence, Risk Factors, and Clinical Characteristics in the RESITRA (Spanish Network of Infection in Transplantation) Cohort
Published in Clinical infectious diseases (15-06-2009)“…Background. It is necessary to clarify the incidence of and risk factors for tuberculosis (TB) among solid-organ transplant (SOT) recipients as well as changes…”
Get full text
Journal Article -
19
Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015
Published in Emerging infectious diseases (01-01-2021)“…Invasive fusariosis (IF) is associated with severe neutropenia in patients with concurrent hematologic conditions. We conducted a retrospective observational…”
Get full text
Journal Article -
20
Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology
Published in Clinical infectious diseases (01-05-2009)“…Tuberculosis is a particularly important condition in solid-organ transplant recipients because of the delay in treatment caused by the difficulties involved…”
Get full text
Journal Article